Royalty’s $8B offer wilts after Elan prevails in blocking bid

Ryan McBride

Royalty Pharma signed the death certificate on its $ 8 billion bid for biotech , withdrawing its appeal of a decision from an Irish panel that blocked its ability to alter the terms of its latest hostile takeover attempt.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS